{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:21:19Z","timestamp":1772490079217,"version":"3.50.1"},"reference-count":47,"publisher":"Japan Endocrine Society","issue":"1","funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2020YFE0204300"],"award-info":[{"award-number":["2020YFE0204300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["Q21H190009"],"award-info":[{"award-number":["Q21H190009"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0317","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T22:13:25Z","timestamp":1727734405000},"page":"53-67","source":"Crossref","is-referenced-by-count":4,"title":["MicroRNA-122 protects against interferon-\u03b1-induced hepatic inflammatory response &lt;i&gt;via&lt;\/i&gt; the Janus kinase\u2013signal transducer and activator of transcription pathway"],"prefix":"10.1507","volume":"72","author":[{"given":"Fanwei","family":"Liu","sequence":"first","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinhua","family":"Ni","sequence":"additional","affiliation":[{"name":"College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 The Lancet Infectious Diseases  (2022) Explaining the unexplained hepatitis in children. Lancet Infect Dis 22: 743.","DOI":"10.1016\/S1473-3099(22)00296-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, et al. (2022) Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol 7: 724\u2013735.","DOI":"10.1016\/S2468-1253(22)00050-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Airewele NE, Shiffman ML (2021) Chronic hepatitis B virus in patients with chronic hepatitis C virus. Clin Liver Dis 25: 817\u2013829.","DOI":"10.1016\/j.cld.2021.06.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, et al. (2006) Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus\/hepatitis C virus-coinfected patients. Hepatology 43: 100\u2013107.","DOI":"10.1002\/hep.20944"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, et al. (2007) Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology 46: 48\u201357.","DOI":"10.1002\/hep.21672"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, et al. (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975\u2013982.","DOI":"10.1056\/NEJMoa020047"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Ye J, Chen J (2021) Interferon and hepatitis B: current and future perspectives. Front Immunol 12: 733364.","DOI":"10.3389\/fimmu.2021.733364"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Pestka S, Langer JA, Zoon KC, Samuel CE (1987) Interferons and their actions. Annu Rev Biochem 56: 727\u2013777.","DOI":"10.1146\/annurev.bi.56.070187.003455"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ji L, Li T, Chen H, Yang Y, Lu E, et al. (2023) The crucial regulatory role of type I interferon in inflammatory diseases. Cell Biosci 13: 230.","DOI":"10.1186\/s13578-023-01188-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Hoffmann HH, Schneider WM, Rice CM (2015) Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol 36: 124\u2013138.","DOI":"10.1016\/j.it.2015.01.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Levy DE, Darnell JE Jr (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651\u2013662.","DOI":"10.1038\/nrm909"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Xu C, Guo H, Pan XB, Mao R, Yu W, et al. (2010) Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J Virol 84: 9332\u20139340.","DOI":"10.1128\/JVI.00918-10"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, et al. (2011) ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol 85: 12881\u201312889.","DOI":"10.1128\/JVI.05633-11"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Pei R, Qin B, Zhang X, Zhu W, Kemper T, et al. (2014) Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication. J Innate Immun 6: 182\u2013191.","DOI":"10.1159\/000353220"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 John SP, Sun J, Carlson RJ, Cao B, Bradfield CJ, et al. (2018) IFIT1 Exerts Opposing Regulatory Effects on the Inflammatory and Interferon Gene Programs in LPS-Activated Human Macrophages. Cell Rep 25: 95\u2013106.E6.","DOI":"10.1016\/j.celrep.2018.09.002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Lodish HF, Zhou B, Liu G, Chen CZ (2008) Micromanagement of the immune system by microRNAs. Nat Rev Immunol 8: 120\u2013130.","DOI":"10.1038\/nri2252"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17 Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, et al. (2008) Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 48: 1810\u20131820.","DOI":"10.1002\/hep.22569"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Hsu SH, Wang B, Kota J, Yu J, Costinean S, et al. (2012) Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122: 2871\u20132883.","DOI":"10.1172\/JCI63539"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577\u20131581.","DOI":"10.1126\/science.1113329"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Hu Y, Peng X, Du G, Zhang Z, Zhai Y, et al. (2022) MicroRNA-122-5p inhibition improves inflammation and oxidative stress damage in dietary-induced non-alcoholic fatty liver disease through targeting FOXO3. Front Physiol 13: 803445.","DOI":"10.3389\/fphys.2022.803445"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21 Lu X, Bao X, Huang Y, Qu Y, Lu H, et al. (2009) Mechanisms of cytotoxicity of nickel ions based on gene expression profiles. Biomaterials 30: 141\u2013148.","DOI":"10.1016\/j.biomaterials.2008.09.011"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Ma L, Lyu W, Song Y, Chen K, Lv L, et al. (2023) Anti-inflammatory effect of clostridium butyricum-derived extracellular vesicles in ulcerative colitis: impact on host microRNAs expressions and gut microbiome profiles. Mol Nutr Food Res 67: e2200884.","DOI":"10.1002\/mnfr.202370029"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Wang Y, Chang L, Zhai J, Wu Q, Wang D, et al. (2017) Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism. J Cell Mol Med 21: 3214\u20133223.","DOI":"10.1111\/jcmm.13225"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Ni Y, Zheng L, Zhang L, Li J, Pan Y, et al. (2024) Spermidine activates adipose tissue thermogenesis through autophagy and fibroblast growth factor 21. J Nutr Biochem 125: 109569.","DOI":"10.1016\/j.jnutbio.2024.109569"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Ma L, Shen Q, Lyu W, Lv L, Wang W, et al. (2022) Clostridium butyricum and its derived extracellular vesicles modulate gut homeostasis and ameliorate acute experimental colitis. Microbiol Spectr 10: e0136822.","DOI":"10.1128\/spectrum.01368-22"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Ni L, Zhuge F, Yang S, Ma L, Zheng A, et al. (2021) Hydrolyzed chicken meat extract attenuates neuroinflammation and cognitive impairment in middle-aged mouse by regulating M1\/M2 microglial polarization. J Agric Food Chem 69: 9800\u20139812.","DOI":"10.1021\/acs.jafc.1c03541"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Ni Y, Ni L, Ma L, Wang Z, Zhao Y, et al. (2021) Neuroprotective effects of ProBeptigen\/CMI-168 on aging-induced cognitive decline and neuroinflammation in mice: a comparison with essence of chicken. Acta Biochim Biophys Sin (Shanghai) 53: 419\u2013429.","DOI":"10.1093\/abbs\/gmab009"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Crockett SD, Keeffe EB (2005) Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob 4: 13.","DOI":"10.1186\/1476-0711-4-13"},{"key":"29","unstructured":"29 Konstantinou D, Deutsch M (2015) The spectrum of HBV\/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management. Ann Gastroenterol 28: 221\u2013228."},{"key":"30","unstructured":"30 Bhattacharya D, Aronsohn A, Price J, Lo Re V, AASLD-IDSA HCV Guidance Panel (2023) Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clin Infect Dis 2023: ciad319."},{"key":"31","doi-asserted-by":"publisher","unstructured":"31 Ghany MG, Morgan TR, AASLD-IDSA Hepatitis C Guidance Panel (2020) Hepatitis C guidance 2019 update: American association for the study of liver diseases-infectious diseases society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology 71: 686\u2013721.","DOI":"10.1002\/hep.31060"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Ivashkiv LB, Donlin LT (2014) Regulation of type I interferon responses. Nat Rev Immunol 14: 36\u201349.","DOI":"10.1038\/nri3581"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33 Tilg H (1997) New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 112: 1017\u20131021.","DOI":"10.1053\/gast.1997.v112.pm9041265"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34 Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, et al. (2014) Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343: 1221\u20131228.","DOI":"10.1126\/science.1243462"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Farooq M, Rauf M, Tahir F, Manzoor S (2021) A comparative analysis of interferons and direct-acting antivirals on the expression of genes involved in hepatitis C pathogenesis. J Med Virol 93: 6241\u20136246.","DOI":"10.1002\/jmv.26351"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Nishio A, Bolte FJ, Takeda K, Park N, Yu ZX, et al. (2021) Clearance of pegylated interferon by Kupffer cells limits NK cell activation and therapy response of patients with HBV infection. Sci Transl Med 13: eaba6322.","DOI":"10.1126\/scitranslmed.aba6322"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Yu P, Li Y, Wang Y, Peppelenbosch MP, Pan Q (2020) Lipopolysaccharide restricts murine norovirus infection in macrophages mainly through NF-kB and JAK-STAT signaling pathway. Virology 546: 109\u2013121.","DOI":"10.1016\/j.virol.2020.04.010"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Geneva-Popova MG, Popova-Belova SD, Gardzheva PN, Kraev KI (2022) A study of IFN-alpha-induced chemokines CCL2, CXCL10 and CCL19 in patients with systemic lupus erythematosu. Life (Basel) 12: 251.","DOI":"10.3390\/life12020251"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Hammerich L, Tacke F (2023) Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol 20: 633\u2013646.","DOI":"10.1038\/s41575-023-00807-x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Bandiera S, Pfeffer S, Baumert TF, Zeisel MB (2015) miR-122\u2014a key factor and therapeutic target in liver disease. J Hepatol 62: 448\u2013457.","DOI":"10.1016\/j.jhep.2014.10.004"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, et al. (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735\u2013739.","DOI":"10.1016\/S0960-9822(02)00809-6"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A (2008) miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 48: 648\u2013656.","DOI":"10.1016\/j.jhep.2008.01.019"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43 Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, et al. (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327: 198\u2013201.","DOI":"10.1126\/science.1178178"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Terenzi F, Hui DJ, Merrick WC, Sen GC (2006) Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem 281: 34064\u201334071.","DOI":"10.1074\/jbc.M605771200"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Li Y, Li C, Xue P, Zhong B, Mao AP, et al. (2009) ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response. Proc Natl Acad Sci U S A 106: 7945\u20137950.","DOI":"10.1073\/pnas.0900818106"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46 Suslov A, Boldanova T, Wang X, Wieland S, Heim MH (2018) Hepatitis B virus does not interfere with innate immune responses in the human liver. Gastroenterology 154: 1778\u20131790.","DOI":"10.1053\/j.gastro.2018.01.034"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Jiang W, Zhang Y, Sheng Y, Liu M, Du C, et al. (2023) Overexpression of IFIT1 protects against LPS-induced acute lung injury <i>via<\/i> regulating CCL5-p65NF-kappaB signaling. Int Immunopharmacol 114: 109485.","DOI":"10.1016\/j.intimp.2022.109485"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0317\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T03:35:19Z","timestamp":1736566519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0317\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0317","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0317"}}